Tuesday, April 16, 2024

Kalbe Farma Partners With Two Japanese Firms to Set Up Rp 100b Clinical Lab

Sarah Yuniarni
January 18, 2018 | 10:34 pm
SHARE
Kalbe Farma announced on Thursday that it has forged partnerships with two Japanese companies, Health Sciences Research Institute (HSRI) and Toyota Tsusho Corporation, to establish a Rp 100 billion ($7 million) clinical laboratory in Sunter, North Jakarta. (JG Photo)
Kalbe Farma announced on Thursday that it has forged partnerships with two Japanese companies, Health Sciences Research Institute (HSRI) and Toyota Tsusho Corporation, to establish a Rp 100 billion ($7 million) clinical laboratory in Sunter, North Jakarta. (JG Photo)

Jakarta. Kalbe Farma, Indonesia's largest pharmaceutical company, announced on Thursday (18/01) that it has forged partnerships with two Japanese companies to establish a Rp 100 billion ($7 million) clinical laboratory in Sunter, North Jakarta.

This will allow Yokohama-based medical laboratory service provider Health Sciences Research Institute (HSRI) and Toyota Tsusho Corporation, a subsidiary of Toyota Motor Corporation, to make inroads in Indonesia's health care sector.

Kalbe and the two Japanese companies have established Innolab Sains Internasional, a joint venture in which the Indonesian company controls 60 percent and HSRI and Toyota Tsusho 20 percent each.

"Through our partnership with these foreign companies, we hope to ensure high quality laboratory services, which will be on par with Japanese standards, and to gain leverage and access to their existing networks. We will also perform a benchmarking process and conduct technology transfers to improve the quality of the laboratory services," Kalbe Farma president director Vidjongtius said in a joint statement on Thursday (18/01).

The Japanese companies see Indonesia's health care industry as an attractive market due to the country's large and expanding population, in addition to complex diseases, that create growing demand for a higher-quality clinical tests, the statement said.

The laboratory, known as Kalgen Innolab Clinical, offers various test services, including advanced molecular diagnostics to support personalized medicine.

Kalgen Innolab Clinical will also offer an international-standard quality management system and integrated laboratory information systems.

"We made a great choice to choose Kalbe as our partner as the company has a wide network in the archipelago and operates a laboratory unit. In the near future, we want to introduce new technologies, such as the Internet of Things [IoT] and artificial intelligence," HSRI president and chief executive Yoshizoh Kugawa told reporters on Wednesday.

HSRI was established in 1950 as Japan's first commercial clinical testing center. It operates 93 sales offices and 52 laboratories, offering a wide range of clinical tests involving biochemistry, hematology, microbiology, oncology, genetics and pathology.

Tags: Keywords:
SHARE

POPULAR READS


News 3 hours ago

President Jokowi Urges Global Restraint as Tensions Rise in the Middle East

President Joko "Jokowi" Widodo emphasized the importance of diplomatic efforts to prevent the escalation of conflict in the Middle East
News 4 hours ago

KPK Identifies Sidoarjo Regent as Suspect in Corruption Probe

KPK has identified Ahmad Muhdlor Ali as a suspect in a corruption case involving the Sidoarjo Regional Tax Service Agency
News 5 hours ago

Economic Concerns Overshadow Security Worries for Indonesians in Iran

Indonesian citizens currently in Iran are more concerned about rising inflation than the security situation in the country.
Lifestyle 5 hours ago

'Siksa Kubur' Review: Indonesian Horror with Solid First Act

The beginning part of "Siksa Kubur" is incredibly solid across many fields, including the visual storytelling. 
Business 5 hours ago

IDX Slides 2 Percent as Geopolitical Conflict Rattles Market Confidence

The IDX attributed the subdued performance of the index at the start of the week to the escalating geopolitical tensions in the Middle East
COPYRIGHT © 2024 JAKARTA GLOBE. ALL RIGHTS RESERVED